SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) Shareholder Notice: Lawsuit Filed Against Takeover
The Shareholders Foundation announces that an investor, who currently holds shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)), filed a lawsuit against the takeover of SciClone Pharmaceuticals, Inc. for $11.18 per share.
View full press release